Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Corticosteroid for 1st CMC Osteoarthritis
NCT06657300Phase 4Completed
- Sponsor
- Antalya Training and Research Hospital
- Start
- Feb 2022
- Primary completion
- Jul 2022
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of platelet-rich plasma in Osteoarthritis of the first carpometacarpal joint (2 arms), sponsored by Antalya Training and Research Hospital. Primary endpoint: Visual Analog Scale at 6 months. Started Feb 2022; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
Osteoarthritis of the first carpometacarpal joint
Beyond the preview
Go deeper on NCT06657300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06657300.